Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Results 1 - 7 of 7 for TRALOKINUMAB
  1. Tralokinumab injection is used to treat moderate to severe eczema (atopic dermatitis; a skin disease that causes ... whose eczema has not responded to topical medications. Tralokinumab is in a class of medications called interleukin- ...
  2. ... ages 6 months and up. Other biologics, including tralokinumab, lebrikizumab and nemolizumab, recently were approved for use ...
  3. Eczema/Images ... Eczema ... VisualDX ... Eczema (atopic dermatitis) is a common, chronic skin condition associated with dry skin that begins with itching or irritation ...
  4. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury From the National Institutes of Health (National Library of Medicine) (National Institute of Diabetes and Digestive and Kidney Diseases)  
    Liver Diseases/Statistics and Research ... Liver Diseases ... Medicines/Statistics and Research ... Medicines ... LiverTox® provides regularly updated, unbiased and easily ...
  5. LactMed: Drugs and Lactation Database From the National Institutes of Health (National Library of Medicine)  
    Breastfeeding/Statistics and Research ... Breastfeeding ... National Library of Medicine ... The LactMed® database contains information on drugs and other chemicals ...
  6. Allergic Skin Conditions (American Academy of Allergy, Asthma, and Immunology)  
    Allergy/Specifics ... Allergy ... Hives/Related Issues ... Hives ... American Academy of Allergy, Asthma, and Immunology ... AAAAI, the experts in allergy and immunology, provide ...
  7. Atopic Dermatitis (While Pregnant or Breastfeeding) (Organization of Teratology Information Specialists)  
    Eczema/Women ... Eczema ... Organization of Teratology Information Specialists